Conditions: Type 2 Diabetes Mellitus
Keywords: Type 2 diabetes mellitus Japanese phase 2 efficacy safety dapagliflozin
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 417
Healthy volunteers: no

Brief summary:
The purpose of this study is to obtain information on efficacy and safety of dapagliflozin in Japanese patients with Type 2 Diabetes. This will be done by comparing the effect of dapagliflozin to placebo when given in oral doses.

Detailed description:

Arms:
arm 1: 1mg dapagliflozin arm 2: 2.5mg dapagliflozin arm 3: 5mg dapagliflozin arm 4: 10mg dapagliflozin arm 5: Placebo

Interventions: intervention 1: Dapagliflozin intervention 2: Placebo
Intervention descriptions: intervention 1: once daily, 12 weeks intervention 2: once daily, 12 weeks

Protocol document: